DCF — ST JUDE MEDICAL CENTER FULLERTON
Enterprise Value: $-548.5M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-548.5M
Enterprise Value
$-183.5M
PV of Cash Flows
$-365.0M
PV of Terminal Value
$-587.9M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $638.8M | $-28.7M | -4.0% | $-55.8M | $-50.7M |
| Year 2 | $658.0M | $-23.0M | -3.0% | $-50.9M | $-42.1M |
| Year 3 | $677.7M | $-16.9M | -2.0% | $-45.6M | $-34.3M |
| Year 4 | $698.0M | $-14.0M | -2.0% | $-43.5M | $-29.7M |
| Year 5 | $719.0M | $-12.6M | -2.0% | $-43.0M | $-26.7M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-548.5M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$620.2M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.04999999935505286
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5